GSK Hit With Thalidomide Birth Defect Suit

Law360, New York (August 9, 2012, 7:23 PM EDT) -- A group of 11 plaintiffs sued GlaxoSmithKline PLC and other pharmaceutical companies in Pennsylvania court Thursday, alleging they suffered birth defects after their mothers took the morning sickness drug thalidomide in the late 1950s and early 1960s.

Thalidomide — which was developed by German pharmaceutical company Gruenenthal GmbH, also named as a defendant — was never approved for distribution by the U.S. Food and Drug Administration, but the plaintiffs say predecessor companies of GSK and Sanofi-Aventis U.S. LLC distributed millions of doses of thalidomide to doctors for human trial.

While it's often been assumed that birth defects related to thalidomide were...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!